J. Yeh

发表

Impact of the N-Terminal Domain of STAT3 in STAT3-Dependent Transcriptional Activity

Guocheng Yuan, T. Hu, D. Frank, 2015, Molecular and Cellular Biology.

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

Wen-Lin Kuo, Jane Fridlyand, Terry Speed, 2006, Cancer cell.

JAK2-STAT5 signaling: A novel mechanism of resistance to targeted PI3K/mTOR inhibition

D. Frank, J. Yeh, Jennifer E. Yeh, 2014 .

Inhibiting STAT5 by the BET Bromodomain Inhibitor JQ1 Disrupts Human Dendritic Cell Maturation

D. Frank, S. R. Walker, P. Moraes-Vieira, 2015, The Journal of Immunology.

This information is current as Maturation CellInhibitor JQ 1 Disrupts Human Dendritic Inhibiting STAT 5 by the BET Bromodomain

José, D. Frank, S. R. Walker, 2015 .

Deregulation of SOCS5 suppresses dendritic cell function in chronic lymphocytic leukemia

Darwin Q. Ye, D. Frank, J. Yeh, 2016, Oncotarget.

Topical imiquimod and cryotherapy in combination with systemic immunotherapy in unresectable stage IIIC melanoma

N. Ibrahim, P. Ott, Jennifer Y. Lin, 2022, JAAD case reports.

Role of BRCA1 in controlling mitotic arrest in ovarian cystadenoma cells

A. Schönthal, J. Yeh, L. Dubeau, 2012, International journal of cancer.

JAK2-STAT5 signaling

D. Frank, J. Yeh, Jennifer E. Yeh, 2013, JAK-STAT.

The STAT3 Target Gene TNFRSF1A Modulates the NF-κB Pathway in Breast Cancer Cells1

D. Frank, J. Yeh, Suhu Liu, 2018, Neoplasia.

Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation

M. Varella‐Garcia, M. Iruela-Arispe, W. Guo, 2008, Nature.

Molecular modulators of the oncogenic transcription factor STAT3

J. Yeh, Jennifer E. Yeh, 2015 .

STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-κB to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes

A. Richardson, B. Groner, N. Birkbak, 2014, Science Signaling.

Acollectionofbreastcancercelllinesforthestudyoffunctionally distinct cancer subtypes

Nicholas J. Wang, T. Speed, P. Spellman, 2006 .

Granulin, a novel STAT3-interacting protein, enhances STAT3 transcriptional function and correlates with poorer prognosis in breast cancer

A. Richardson, D. Frank, A. Ivanov, 2015, Genes & cancer.

Targeting transcription factors: promising new strategies for cancer therapy

David A. Frank, D. Frank, J. Yeh, 2013, Current opinion in oncology.

STAT3‐Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer Therapy

D. Frank, J. Yeh, Jennifer E. Yeh, 2016, ChemMedChem.

STAT5 Outcompetes STAT3 To Regulate the Expression of the Oncogenic Transcriptional Modulator BCL6

Guocheng Yuan, D. Frank, J. Yeh, 2013, Molecular and Cellular Biology.

Granulin , a novel STAT 3-interacting protein , enhances STAT 3 transcriptional function and correlates with poorer prognosis in breast cancer

A. Richardson, D. Frank, A. Ivanov, 2015 .

A conditional feedback loop regulates Ras activity through EphA2.

R. Neve, J. Gray, Chira Chen, 2005, Cancer cell.

Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors: A Systematic Review.

E. Nadelmann, J. Yeh, Jennifer E. Yeh, 2021, JAMA oncology.

Topical imiquimod in combination with brachytherapy for unresectable cutaneous melanoma scalp metastases

Ivan Buzurovic, P. Devlin, N. Ibrahim, 2022, JAAD case reports.

The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductase

D. Frank, Boryana Petrova, J. Yeh, 2021, The Journal of biological chemistry.

Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses

Zachary T. Giaccone, S. Tyekucheva, Catherine J. Wu, 2020, American journal of hematology.